A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Clinical trial NCT05698043 · COMPLETED

Trial details

NCT number: NCT05698043
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension and Dyslipidemia

Start date: 2023-07-17
Primary completion: 2023-09-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.